# Scopolamine Transdermal System

NDC: 45802-580
Generic name: scopolamine transdermal system
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PATCH, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20170613
Marketing ended: 20280630
FDA application: ANDA078830

## Active ingredients

- SCOPOLAMINE: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-580"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-580
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb93bfad-3e37-4a27-92f6-f21703ae7bdf